Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022

登录注册会员服务联系我们

Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023

Published:2024-09-13 Issue: Volume: Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Yu Patricia A.¹,Elmor Riad²,Muhammad Kalimah¹³,Yu Yon C.¹,Rao Agam K.⁴

Affiliation:

1. Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta

2. Booz Allen Hamilton, McLean, VA

3. Cherokee Nation Integrated Health, Tulsa, OK

4. Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta

Publisher

Massachusetts Medical Society

Reference43 articles.

1. Smallpox as a Biological Weapon

2. SIGA Technologies Inc. TPOXX prescribing information. 2022 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208627s007lbl.pdf).

3. U.S. Food and Drug Administration. Animal rule information. March 25 2024 (https://www.fda.gov/emergency-preparedness-and-response/mcm-regulatory-science/animal-rule-information)

4. U.S. Food and Drug Administration. FDA approves the first drug with an indication for treatment of smallpox. July 13 2018 (https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-indication-treatment-smallpox).

5. Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP